Literature DB >> 12464346

Genotoxicity of hyperbaric oxygen.

Günter Speit1, Claudia Dennog, Peter Radermacher, Andreas Rothfuss.   

Abstract

Hyperbaric oxygen (HBO) treatment is applied as a therapy for a wide variety of diseases with symptoms caused by lack of oxygen in the target tissues. However, it is known that exposure to high concentrations of oxygen may lead to oxidative stress and cause cell and tissue damage. Oxygen toxicity and possible cancer-promoting effects of HBO therapy have been a matter of serious concern. Although a cancer-inducing effect of HBO was not found to date, recent studies clearly indicated an induction of oxidative DNA damage in blood cells of healthy subjects after HBO under therapeutic conditions. The biological significance of this finding has been investigated in a series of in vitro and in vivo tests. This review summarizes these studies and critically discusses potential adverse genetic effects of HBO therapy. Furthermore, since an induction of anti-oxidative defense mechanisms has been determined after HBO exposure, a modified treatment regimen of HBO therapy is proposed which avoids genotoxic effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464346     DOI: 10.1016/s1383-5742(02)00045-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  Hyperbaric oxygen and sepsis: time to recognize.

Authors:  Claus-Martin Muth; Peter Radermacher; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2005-07-21       Impact factor: 17.440

2.  Safety and whole-body antioxidant potential of a novel anthocyanin-rich formulation of edible berries.

Authors:  Debasis Bagchi; Sashwati Roy; Viren Patel; Guanglong He; Savita Khanna; Navdeep Ojha; Christina Phillips; Sumona Ghosh; Manashi Bagchi; Chandan K Sen
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  Enhancement of reactive oxygen species and induction of apoptosis in streptozotocin-induced diabetic rats under hyperbaric oxygen exposure.

Authors:  Tokio Matsunami; Yukita Sato; Yuki Hasegawa; Satomi Ariga; Haruka Kashimura; Takuya Sato; Masayoshi Yukawa
Journal:  Int J Clin Exp Pathol       Date:  2011-02-20

4.  Effects of a cantaloupe melon extract/wheat gliadin biopolymer during aortic cross-clamping.

Authors:  Jochen Kick; Balázs Hauser; Hendrik Bracht; Maura Albicini; Sükrü Oter; Florian Simon; Ulrich Ehrmann; Catherine Garrel; Jörn Sträter; Uwe B Brückner; Xavier M Leverve; Hubert Schelzig; Günter Speit; Peter Radermacher; Claus-Martin Muth
Journal:  Intensive Care Med       Date:  2007-01-20       Impact factor: 17.440

5.  Oxidative stress and gene expression of antioxidant enzymes in the streptozotocin-induced diabetic rats under hyperbaric oxygen exposure.

Authors:  Tokio Matsunami; Yukita Sato; Takuya Sato; Satomi Ariga; Toshiko Shimomura; Masayoshi Yukawa
Journal:  Int J Clin Exp Pathol       Date:  2009-11-30

6.  Topical oxygen therapy induces vascular endothelial growth factor expression and improves closure of clinically presented chronic wounds.

Authors:  Gayle M Gordillo; Sashwati Roy; Savita Khanna; Richard Schlanger; Sorabh Khandelwal; Gary Phillips; Chandan K Sen
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-04-21       Impact factor: 2.557

7.  Effect of Hyperbaric Oxygen on Proliferation and Gene Expression of Human Chondrocytes: An In Vitro Study.

Authors:  Carolin Melcher; Birte Sievers; Nadine Höchsmann; Frank Düren; Volkmar Jansson; Peter E Müller
Journal:  Cartilage       Date:  2018-03-27       Impact factor: 4.634

8.  Re-evaluate the effect of hyperbaric oxygen therapy in cancer - a preclinical therapeutic small animal model study.

Authors:  Sneha Pande; Amit Sengupta; Anurag Srivastava; Rajiv P Gude; Arvind Ingle
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Protective Effect of Edaravone against Carbon Monoxide Induced Apoptosis in Rat Primary Cultured Astrocytes.

Authors:  Xiaodan Xu; Hong Zhang; Ke Wang; Tao Tu; Yuan Jiang
Journal:  Biochem Res Int       Date:  2017-02-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.